International
Aiforia Announces Closing of €17.5M Series B Funding Round
Financing to accelerate Aiforia’s development and continuing expansion of AI solutions for image analysis in clinical diagnostics and preclinical pathology. HELSINKI, Sept 16, 2021 -- Aiforia, a software company providing AI-based solutions...
NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...
Symposium | Pathologist-led Development of Deep Learning Models for...
Register Now AIRA Matrix invites you to a symposium on the development and validation of Deep Learning algorithms for the detection and quantification of the major features of Progressive Cardiomyopathy (PCM) in rodents. Rodent PCM...
Swifter discovery can improve life expectancy A longer life expectancy goes hand in hand with the risk of cancer. The Hamburg-based Mindpeak is developing artificial intelligence to help pathologists diagnose cancer swiftly. Until now,...
It enables every actor in Pathology to run digital image analysis in the context of clinical trials, as in CAP/CLIA laboratories, with unprecedented efficiency. This AI-platform strengthens Keen Eye's strategic positioning in the clinical...
In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites. STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing...
